Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry.

OBJECTIVE In women with diabetes, the changes that accompany menopause may further diminish glycemic control. Little is known about how hormone replacement therapy (HRT) affects glucose metabolism in diabetes. The aim of this study was to examine whether HbA(1c) levels varied by current HRT among women with type 2 diabetes. RESEARCH DESIGN AND METHODS In a cohort of 15,435 women with type 2 diabetes who were members of a health maintenance organization, HbA(1c) and HRT were assessed by reviewing records in the health plan's computerized laboratory and pharmacy systems. Sociodemographic and clinical information were collected by survey. RESULTS The mean age was 64.7 years (SD +/- 8.7). The study cohort comprised 55% non-Hispanic whites, 14% non-Hispanic blacks, 12% Hispanics, 11% Asians, 4% "other" ethnic groups, and 4% with missing ethnicity data. Current HRT was observed in 25% of women. HbA(1c) levels were significantly lower in women currently using HRT than in women not using HRT (age-adjusted mean +/- SE: 7.9 +/- 0.03 vs. 8.5 +/- 0.02, respectively, P = 0.0001). No differences in HbA(1c) level were observed between women using unopposed estrogens and women using opposed estrogens. In a Generalized Estimating Equation model, which took into account patient clustering within physician and adjusted for age, ethnicity, education, obesity, hypoglycemic therapy, diabetes duration, self-monitoring of blood glucose, and exercise, HRT remained significantly and independently associated with decreased HbA(1c) levels (P = 0.0001). CONCLUSIONS HRT was independently associated with decreased HbA(1c) level. Clinical trials will be necessary to understand whether HRT may improve glycemic control in women with diabetes.

[1]  R. Holman,et al.  Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.

[2]  C. Hayward,et al.  Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study. , 1999, Diabetes care.

[3]  Paul Cleary,et al.  Use of Hormone Replacement Therapy by Postmenopausal Women in the United States , 1999, Annals of Internal Medicine.

[4]  A. Zaslavsky,et al.  Annals of Internal Medicine Use of Hormone Replacement Therapy by Postmenopausal Women in the United States , 1999 .

[5]  K. Brett,et al.  Racial differences in hormone replacement therapy prescriptions , 1999 .

[6]  R. D'Agostino.  Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .

[7]  B. Ettinger,et al.  Evaluation and interference study of hemoglobin A1c measured by turbidimetric inhibition immunoassay. , 1998, American journal of clinical pathology.

[8]  J. Selby,et al.  Excess Costs of Medical Care for Patients With Diabetes in a Managed Care Population , 1997, Diabetes Care.

[9]  J. Madans,et al.  Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. , 1997, American journal of epidemiology.

[10]  P. Björntorp,et al.  Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus. , 1997, The Journal of clinical endocrinology and metabolism.

[11]  M. Frölich,et al.  Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM , 1997, Diabetologia.

[12]  A. Sevanian,et al.  Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein. , 1997, Fertility and sterility.

[13]  N. Sattar,et al.  Hormone Replacement Therapy and Cardiovascular Risk in Post‐menopausal Women with NIDDM , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[14]  K. Matthews,et al.  Prior to use of estrogen replacement therapy, are users healthier than nonusers? , 1996, American journal of epidemiology.

[15]  E. Poehlman,et al.  Changes in Energy Balance and Body Composition at Menopause: A Controlled Longitudinal Study , 1995, Annals of Internal Medicine.

[16]  V. Salomaa,et al.  Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors. The FINRISK Hemostasis Study. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[17]  E. Barrett-Connor,et al.  Sex Differences in Insulin Levels in Older Adults and the Effect of Body Size, Estrogen Replacement Therapy, and Glucose Tolerance Status: The Rancho Bernardo Study, 1984–1987 , 1995, Diabetes Care.

[18]  Susan R. Johnson,et al.  Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial , 1995 .

[19]  B. Walsh,et al.  Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women , 1994, Obstetrics and gynecology.

[20]  R. Lobo,et al.  The route of administration influences the effect of estrogen on insulin sensitivity in postmenopausal women. , 1994, Fertility and sterility.

[21]  C. Cobelli,et al.  The effects of hormonal replacement therapy on insulin sensitivity in surgically postmenopausal cynomolgus monkeys (Macaca fascicularis). , 1994, American journal of obstetrics and gynecology.

[22]  P. Björntorp,et al.  Muscle Fiber Composition and Capillary Density in Women and Men With NIDDM , 1994, Diabetes Care.

[23]  I. Godsland,et al.  HRT mechanisms of action: carbohydrates. , 1994, International journal of fertility and menopausal studies.

[24]  R. Lobo,et al.  A possible bimodal effect of estrogen on insulin sensitivity in postmenopausal women and the attenuating effect of added progestin. , 1993, Fertility and sterility.

[25]  A. Folsom,et al.  Association of Hormone-Replacement Therapy With Various Cardiovascular Risk Factors in Postmenopausal Women , 1993 .

[26]  I. Godsland,et al.  Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. , 1993, Metabolism: clinical and experimental.

[27]  A. Folsom,et al.  Association of Hormone-Replacement Therapy with Various Cardiovascular Risk Factors in Postmenopausal Women , 1993 .

[28]  P. Fioretti,et al.  Effects of low doses of transdermal 17 beta-estradiol on carbohydrate metabolism in postmenopausal women. , 1992, The Journal of clinical endocrinology and metabolism.

[29]  N. Krieger.  Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.

[30]  M. Napoli,et al.  Postmenopausal Estrogen and Prevention Bias , 1992, Annals of Internal Medicine.

[31]  C. Christiansen,et al.  Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. , 1991, Metabolism: clinical and experimental.

[32]  M. Laakso,et al.  Ischemic heart disease risk in postmenopausal women. Effects of estrogen use on glucose and insulin levels. , 1990, Arteriosclerosis.

[33]  K. Matthews,et al.  Menopause and risk factors for coronary heart disease. , 1990, The New England journal of medicine.

[34]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[35]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[36]  L. Wallentin,et al.  METABOLIC AND HORMONAL EFFECTS OF POST-MENOPAUSAL OESTROGEN REPLACEMENT TREATMENT , 1977 .

[37]  L. Wallentin,et al.  Metabolic and hormonal effects of post-menopausal oestrogen replacement treatment. I. Glucose, insulin and human growth hormone levels during oral glucose tolerance tests. , 1977, Acta endocrinologica.

[38]  M. L. Matute,et al.  Sex steroid influence on hepatic gluconeogenesis and glucogen formation. , 1973, Endocrinology.